Xiaotian Zhang

机构：Renji Hospital, Dian Diagnostics (China), Baoji City Central Hospital, Huazhong University of Science and Technology, Nanjing Medical University, Temple University · ORCID：0000-0001-5267-7871

发表论文 254 篇 · 总被引 7368 次 · h-index 40

代表论文

• Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 56)
• Overview of host-directed antiviral targets for future research and drug development (2025 · Acta Pharmaceutica Sinica B · 被引 26)
• Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2 -Positive Locally Advanced Resectable Gastric Cancer (2025 · JAMA Oncology · 被引 19)
• Exploring the dynamics of self-efficacy, resilience, and self-management on quality of life in type 2 diabetes patients: A moderated mediation approach from a positive psychology perspective (2025 · PLoS ONE · 被引 9)
• Enhancing human pluripotent stem cell differentiation to cardiomyocytes through cardiac progenitor reseeding and cryopreservation (2025 · iScience · 被引 8)
• Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy (2025 · American Journal of Nephrology · 被引 6)